← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 1989Last known activity
Apr 22, 2023
Timeline
1950s
- Jan 1, 1956
Southwest Oncology Group— Founded
Drugs by trial phase (245 distinct, 402 trials)
Phase 3 (149 own, 0 via acquisition)
Phase 2 (93 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Mucinous
- Adenocarcinoma of Lung
- Adenocarcinoma, Papillary
- Adenoma
- Adrenocortical Carcinoma
- Amyloidosis
- Anemia, Refractory, with Excess of Blasts
- Anus Neoplasms
- Arthralgia
- Basal Cell Carcinoma
- Bile Duct Neoplasms
- Biliary Tract Neoplasms
- Brain Neoplasms
- Breast Carcinoma In Situ
- Breast Neoplasms
- Burkitt Lymphoma
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Ductal, Breast
- Carcinoma, Endometrioid
- Carcinoma, Giant Cell
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Large Cell
- Carcinoma, Merkel Cell
- Carcinoma, Mucoepidermoid
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Cardiotoxicity
- Cataract
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Chondrosarcoma
- Chordoma
- Choriocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Constipation
- Cystadenocarcinoma
- Cystadenocarcinoma, Mucinous
- Cystadenocarcinoma, Serous
- Dermatofibrosarcoma
- Desmoid Tumors
- Diarrhea
- Endometrial Neoplasms
- Ependymoma
- Esophageal Neoplasms
- Eye Neoplasms
- Fallopian Tube Neoplasms
- Fatigue
- Fibroma
- Fibrosarcoma
- Gallbladder Neoplasms
- Gastrointestinal Hemorrhage
- Gastrointestinal Stromal Tumors
- Gestational Trophoblastic Disease
- Glioblastoma
- Gliosarcoma
- Head and Neck Neoplasms
- Hemangiopericytoma
- Hemangiosarcoma
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatomegaly
- Hodgkin Disease
- Hot Flashes
- Hutchinson's Melanotic Freckle
- Hypercalcemia
- Hypereosinophilic Syndrome
- Immunoblastic Lymphadenopathy
- Immunoglobulin Light-chain Amyloidosis
- Infertility
- Inflammatory Breast Neoplasms
- Intestinal Neoplasms
- Intraocular Lymphoma
- Kidney Neoplasms
- Klatskin Tumor
- Laryngeal Diseases
- Laryngeal Neoplasms
- Leiomyosarcoma
- Lentigo
- Leukemia
- Leukemia, Basophilic, Acute
Recent trials (50)
- NCT05642572Lead sponsorPhase 2Apr 22, 2023
- NCT05642572Overall official - principal investigatorPhase 2Apr 22, 2023
- NCT05554406Overall official - principal investigatorPhase 2Feb 28, 2023
- NCT05564390Overall official - principal investigatorPhase 2Feb 28, 2023
- NCT05633602Lead sponsorPhase 3Dec 15, 2022
- NCT05633602Overall official - principal investigatorPhase 3Dec 15, 2022
- NCT05554380Overall official - principal investigatorPhase 2Dec 9, 2022
- NCT05411081Overall official - principal investigatorPhase 2Sep 19, 2022
- NCT05364645Lead sponsorPhase 2Jul 25, 2022
- NCT05364645Overall official - principal investigatorPhase 2Jul 25, 2022
- NCT05308446Overall official - principal investigatorPhase 2Jun 6, 2022
- NCT05096663Overall official - principal investigatorPhase 2/Phase 3Apr 28, 2022
- NCT05096663Lead sponsorPhase 2/Phase 3Apr 28, 2022
- NCT05136196Overall official - principal investigatorPhase 2Feb 5, 2022
- NCT05040360Lead sponsorPhase 2Jan 12, 2022
Details
- Founded
- Houston, Texas, US Jan 1, 1956
- Last known activity
- Apr 22, 2023